Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-20 9:02 pm Purchase |
2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX |
Seven Fleet Partners LP | 377,161 0.200% |
377,161 (New Position) |
Filing History |
| 2025-05-20 9:00 pm Purchase |
2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX |
Longitude Capital Partners V, LLC | 11,538,461 7.300% |
11,538,461 (New Position) |
Filing History |
| 2025-05-20 4:25 pm Purchase |
2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX |
Venrock Healthcare Capital Partners III, L.P. | 12,992,500 8.200% |
12,992,500 (New Position) |
Filing History |
| 2025-05-15 4:15 pm Sale |
2025-03-31 | 13G | CytomX Therapeutics, Inc. CTMX |
TANG CAPITAL MANAGEMENT, LLC | 6,717,825 8.400% |
-1,093,935 (-14.00%) |
Filing History |
| 2025-05-14 5:14 pm Purchase |
2025-05-12 | 13G | CytomX Therapeutics, Inc. CTMX |
Point72 Asset Management, L.P. | 13,094,400 8.300% |
13,094,400 (New Position) |
Filing History |
| 2025-02-14 11:34 am Sale |
2024-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-4,809,518 (Position Closed) |
Filing History |
| 2024-11-14 4:26 pm Purchase |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 8,089,795 9.990% |
1,386,906 (+20.69%) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
TANG CAPITAL MANAGEMENT, LLC | 7,811,760 9.990% |
7,811,760 (New Position) |
Filing History |
| 2024-11-14 3:03 pm Sale |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
Cormorant Asset Management LP | 0 0.000% |
-5,750,000 (Position Closed) |
Filing History |
| 2024-11-14 12:28 pm Purchase |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
JANUS HENDERSON GROUP PLC JHG |
4,809,518 6.200% |
651,408 (+15.67%) |
Filing History |
| 2024-05-22 4:06 pm Purchase |
2024-05-13 | 13G | CytomX Therapeutics, Inc. CTMX |
JANUS HENDERSON GROUP PLC JHG |
4,158,110 5.300% |
4,158,110 (New Position) |
Filing History |
| 2024-05-13 4:00 pm Purchase |
2024-05-02 | 13G | CytomX Therapeutics, Inc. CTMX |
Cormorant Asset Management LP | 5,750,000 7.380% |
5,750,000 (New Position) |
Filing History |
| 2024-02-14 4:00 pm Purchase |
2023-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
TANG CAPITAL PARTNERS LP | 6,550,000 9.800% |
3,039,555 (+86.59%) |
Filing History |
| 2024-02-14 10:09 am Purchase |
2023-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 6,702,889 9.990% |
107,088 (+1.62%) |
Filing History |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | CytomX Therapeutics, Inc. CTMX |
The Vanguard Group | 4,902,943 7.320% |
317,222 (+6.92%) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
Point72 Asset Management, L.P. | 0 0.000% |
-6,312,371 (Position Closed) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
TANG CAPITAL PARTNERS LP | 3,510,445 5.300% |
39,545 (+1.14%) |
Filing History |
| 2023-02-14 10:22 am Sale |
2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
RTW Investments, LP | 0 0.000% |
-6,029,700 (Position Closed) |
Filing History |
| 2023-02-09 11:16 am Sale |
2022-12-30 | 13G | CytomX Therapeutics, Inc. CTMX |
The Vanguard Group | 4,585,721 6.940% |
-522,270 (-10.22%) |
Filing History |
| 2022-07-29 4:37 pm Purchase |
2022-07-27 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 6,595,801 10.100% |
792,101 (+13.65%) |
Filing History |